Inhye Ahn, MD
Dr. Ahn is a member of the Faculty of Medicine at Dana-Farber Cancer Institute specializing in the care of patients with chronic lymphocytic leukemia (CLL). She earned her medical degree from Catholic University of Korea and completed residency at The Methodist Hospital in Houston, TX combined with laboratory research training at MD Anderson Cancer Center. She completed hematology/oncology fellowship training at the National Institutes of Health. Her research highlighted patterns and molecular mechanisms of resistance to BTK inhibitors and led to the development of a novel prognostic tool specific to CLL patients receiving targeted therapy. Her goal as an investigator is to develop innovative therapies and individualized care for patients with CLL.
Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA